senicapoc has been researched along with decitabine in 1 studies
| Studies (senicapoc) | Trials (senicapoc) | Recent Studies (post-2010) (senicapoc) | Studies (decitabine) | Trials (decitabine) | Recent Studies (post-2010) (decitabine) |
|---|---|---|---|---|---|
| 42 | 3 | 32 | 3,804 | 205 | 2,177 |
| Protein | Taxonomy | senicapoc (IC50) | decitabine (IC50) |
|---|---|---|---|
| DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliyu, ZY; Kato, GJ; Tumblin, AR | 1 |
1 other study(ies) available for senicapoc and decitabine
| Article | Year |
|---|---|
Current therapy of sickle cell disease.
Topics: Acetamides; Anemia, Sickle Cell; Azacitidine; Butyrates; Decitabine; Erythrocyte Transfusion; Humans; Hydroxyurea; Nitric Oxide; Trityl Compounds | 2006 |